Dr Reddys Laboratories RDY
NYSE RDY
$12.85 +0.34 (+2.68%)
As of: Sep 29, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Non-Current Debt (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) reported Non-Current Debt of $150.67 million for the quarter ended Jun 30, 2026, down 24.3% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Non-Current Debt (2009 - 2026) Analysis & Trends

As of Mar 31, 2026, Dr Reddys Laboratories posted Non-Current Debt of $130 million, up 41.3% from the prior year.

  • Non-Current Debt has a five-year compound annual growth rate of 8.6% (years ended Mar 2021 to Mar 2026).
  • By year, Non-Current Debt came in at $92 million in the year ended Mar 31, 2025 (+27.8%), $72 million in the year ended Mar 31, 2024 (-56.1%), $164 million in the year ended Mar 31, 2023 (+115.8%) and $76 million in the year ended Mar 31, 2022 (-11.6%).
  • Five-year quarterly Non-Current Debt spans a low of $15.55 million in the quarter ended Mar 31, 2023 and a high of $301 million in the quarter ended Jun 30, 2022.
  • Year over year, Non-Current Debt gained in five of the last six quarters, with growth averaging 55.9%.
  • The high point for year-over-year Non-Current Debt in five years was the quarter ended Mar 31, 2024 (growth of 364.0%); the low point was the quarter ended Mar 31, 2023 (a decline of 79.7%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $199.16 million (quarter ended Mar 31, 2026), $195.91 million (quarter ended Dec 31, 2025) and $133.42 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Dr Reddys Laboratories 10.44 Bn 9.62 Bn 396.53 Mn 150.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 150.67 Mn
Mar 31, 2026 199.16 Mn
Dec 31, 2025 195.91 Mn
Sep 30, 2025 133.42 Mn
Mar 31, 2025 90.81 Mn
Dec 31, 2024 89.76 Mn
Sep 30, 2024 87.89 Mn
Jun 30, 2024 74.67 Mn
Mar 31, 2024 72.13 Mn
Dec 31, 2023 73.88 Mn
Sep 30, 2023 89.26 Mn
Jun 30, 2023 153.00 Mn
Mar 31, 2023 15.55 Mn
Dec 31, 2022 75.45 Mn
Sep 30, 2022 81.73 Mn
Jun 30, 2022 301.00 Mn
Mar 31, 2022 76.42 Mn
Dec 31, 2021 91.20 Mn
Sep 30, 2021 93.03 Mn
Jun 30, 2021 95.94 Mn
API Access

Dr Reddys Laboratories Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=RDY&period=max&api_key=YOUR_API_KEY